(Q28306292)
Statements
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer (English)
0 references
April 2006
0 references
29
0 references
2
0 references
109-15
0 references